Skip to main content
. 2010 Aug;5(8):1489–1496. doi: 10.2215/CJN.02130310

Table 1.

Baseline characteristics according to the mode of renal replacement therapy before and after propensity score matching

Overall
P Propensity-Matched
SDi
IHD (n = 470) CRRT (n = 266) IHD (n = 158) CRRT (n = 158)
Patients, n (%)
    Age (years; mean [SD]) 65.7 (15.0) 63.7 (14.5) 0.08 65.2 (14.3) 65.6 (13.6) 2.9
    Male 314 (66.8) 180 (67.7) 0.82 99 (62.7) 116 (73.4) 23.2
    Body mass index (mean [SD]) 26.5 (5.2) 26.9 (5.5) 0.37 27.1 (5.7) 26.9 (5.3) 3.6
    SAPS II score (SD) 56.3 (19.6) 65.6 (22.3) <0.0001 59.0 (20.7) 61.7 (22.0) 12.6
    Number of organ failure (mean [SD]) 2.2 (1.2) 2.9 (1.1) <0.0001 2.5 (1.1) 2.5 (1.1) 0
    McCabe score (mean [SD]) 1.4 (0.7) 1.6 (0.7) <0.003 1.6 (0.8) 1.5 (0.7) 13.3
    Ventilated (mean [SD]) 289 (61.5) 237 (89.1) <0.0001 128 (81.0) 132 (83.5) 6.6
    Coma Glasgow scale (mean [SD]) 11.4 (4.9) 10.1 (5.3) <0.002 11.2 (4.9) 11.0 (5.0) 4.0
    Cardiac rhythm (mean [SD]) 98 (38) 108 (41) <0.001 109.0 (38.3) 105.3 (40.5) 9.4
    Arterial pressure (mmHg; mean [SD]) 70.4 (28.2) 59.1 (24.9) <0.0001 64.7 (26.0) 63.1 (27.2) 6.0
    Days from admission to inclusion (mean [SD]) 2.4 (5.8) 3.1 (7.7) 0.24 3.8 (5.7) 3.7 (9.5) 1.3
    Body temperature (°C; mean [SD]) 36.8 (1.9) 36.9 (2.5) 0.43 36.9 (2.1) 37.0 (2.4) 4.4
    White blood cell count (cells/μl; mean [SD]) 13,889 (9525) 14,879 (10,037) 0.2 14,479 (10,201) 13,999 (8158) 5.2
    Platelets count (cells/ml; mean [SD]) 191,190 (127,190) 161,410 (134,740) <0.004 163,030 (117,520) 173,030 (114,990) 8.6
    Prothrombin rate (%; mean [SD]) 58.3 (22.7) 47.4 (23.5) <0.0001 53.7 (22.4) 53.8 (23.8) 0.4
    pH (mean [SD]) 7.274 (0.154) 7.227 (0.175) <0.0005 7.267 (0.167) 7.262 (0.160) 3.1
    Kaliemia (mmol/L; mean [SD]) 4.7 (1.4) 4.5 (1.2) 0.07 4.54 (1.28) 4.50 (1.18) 4.1
    Lactate levels (mean [SD]) 4.3 (4.0) 6.2 (5.1) <0.0001 4.6 (3.9) 4.7 (4.0) 2.5
    Bicarbonates (mean [SD]) 17.2 (6.2) 18.0 (7.1) 0.16 18.6 (7.7) 18.5 (6.9) 1.4
    Urea (mmol/L; mean [SD]) 24.6 (15.6) 17.7 (10.6) <0.0001 19.8 (13.0) 19.6 (11.8) 1.6
    Serum creatinine (μmol/L; mean [SD]) 366.9 (304.7) 252.6 (144.4) <0.0001 256.8 (154.8) 267.9 (158.0) 7.1
    Urine output (ml/d; mean [SD]) 991 (1009) 826 (924) <0.03 962 (768) 922 (942) 4.7
    Hematocrit (%; mean [SD]) 30.8 (8.3) 29.9 (8.2) 0.15 31.0 (8.3) 31.2 (8.0) 2.5
    Hemoglobin (g/dl: mean [SD]) 10.36 (2.90) 10.13 (3.29) 0.37 10.36 (2.64) 10.33 (2.58) 1.5
    Received systemic antibiotics (n [%]) 247 (52.6) 205 (77.1) <0.0001 116 (73.4) 115 (72.8) 4.1
    Vasopressive support 274 (58.3) 216 (81.2) <0.0001 106 (67.1) 109 (69.0) 4.1
    Immunosuppression 86 (18.3) 41 (15.4) 0.32 31 (19.6) 21 (13.3) 17.1
    Diabetes 131 (27.9) 61 (22.9) 0.15 45 (28.5) 41 (26.0) 5.7
    Hypertension 238 (50.6) 120 (45.1) 0.15 81 (51.3) 80 (50.6) 1.3
Catheter (n [%])
        Antiseptic-impregnated catheter 150 (31.9) 11 (4.1) <0.0001 10 (6.3) 10 (6.3) 0
catheter site
    Femoral (versus jugular) 232 (49.4) 138 (51.9) 0.52 74 (46.8) 85 (53.8) 14.0
Days of insertion
    Mean (SD) 6.3 (6.2) 6.6 (6.0) 0.53 8.6 (7.9) 7.2 (6.0) 20.0
    Median (IQR) 5 (2 to 8) 5 (2 to 9) 0.31 6 (3 to 11) 6 (3 to 10) NA
Conditional probability to receive IHD
    Mean (SD) 0.76 (0.23) 0.42 (0.23) <0.0001 0.54 (0.19) 0.53 (0.20) NA
    Median (IQR) 0.83 (0.60 to 0.95) 0.40 (0.24 to 0.59) <0.0001 0.52 (0.40 to 0.65) 0.52 (0.40 to 0.66) NA

Sdi, standardized difference; NA, not applicable.